Sorrento Therapeutics's market cap is currently $2.76M. The company's EPS TTM is $; its P/E ratio is ―; Sorrento Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22
Dec 21
Dec 20
Dec 19
Dec 18
Currency in USD
Sorrento Therapeutics Earnings and Revenue History
